Google+ Facebook Twitter Twitter

Tech round up: June 2024

Best new tech this month

eProtein Discovery side-CREDIT_Supplied


Protein expression optimization

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, has successfully completed 11 installs of its eProtein Discovery system. Custom protein reagents, required in drug discovery, are challenging to manufacture both in terms of cost and time associated. The eProtein Discovery platform overcomes this unmet need by providing rapid access to challenging proteins in a benchtop system in less than 48 hours.

StarBright Red Dyes Extended - CREDIT_Supplied.

Bio-Rad Laboratories

Antibody markers

Bio-Rad Laboratories has launched three new StarBright Red Dyes – StarBright Red 715, 775, and 815 – and an expansion of its StarBright Violet Dye series with 29 additional highly validated antibodies conjugated to StarBright Violet 570, 515, 440, 670, 790, and 475 dyes. Now totalling 32 dyes spanning multiple lasers, Bio-Rad’s range of StarBright Dyes expands translational and immunological research.

Broken String Biosciences

Cell and gene therapies

Broken String Biosciences, a genomics company working on next-generation cell and gene therapies, has entered a research collaboration with the Francis Crick Institute. In partnership with researchers at the Crick, the project aims to develop novel applications for Broken String’s proprietary DNA break-mapping platform, INDUCE-seq, beyond its established capabilities in gene-editing. The research will be focused on leveraging the technology to investigate the impact of genomic instability in the development of amyotrophic lateral sclerosis – a debilitating neurodegenerative disease.

Image credit | Supplied

Related Articles

Natural-killer cells attacking a cancer cel - CREDIT - Science-Photolibrary-f0339843

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Vaccine bottle - CREDIT - iStock-Shutterstock-Various

Personalised vaccines: A pioneering new immunotherapy

A look at the international trial of the world’s first personalised mRNA cancer immunotherapy for melanoma and its potential translation to other cancers and diseases.

Oxford Autoimmune Neurology Diagnostic Laboratory -CREDIT-Supplied

My lab: antibodymediated autoimmune neurology

A guided tour of the Oxford Autoimmune Neurology Diagnostic Laboratory.

blood sample-CREDIT-shutterstock-631151198

Vaccine for highly fatal tropical disease

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease.